Clinical Trial Update: CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 trial evaluating CMP-001 and INCAGN01949 for stage IV pancreatic cancer and other non-melanoma solid tumors was terminated; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CMP-001
• INCAGN01949

Snippet

Sponsor: University of Southern California | Conditions: Locally Advanced Malignant Solid Neoplasm, Metastatic Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-02-17